Lobe Sciences announces non-brokered private placement of 24,705,880 shares at $0.085 each for $2.1 million gross proceeds
Reuters2026/08/12 12:46- Lobe Sciences launched a non-brokered private placement of 24,705,880 common shares priced at $0.085 each.
- Gross proceeds expected at about $2.1 million.
- Funds earmarked for cash reserves, clinical development of the S-100 molecule, working capital, general corporate purposes.
- Shares issued subject to a four-month hold period under Canadian securities laws.
- Securities not registered under the U.S. Securities Act; no offers or sales in the U.S. without an exemption.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
For the first time in over a year, the open interest share of altcoins has surpassed that of bitcoin.
OPEC+ agrees to keep oil output policy unchanged for October
US military strikes Iranian oil tanker, triggering geopolitical risks as Brent crude nears $97 mark
Following the US military's attack on Iranian oil tankers and Iran's announcement of new restricted navigation zones outside the Strait of Hormuz, market concerns over prolonged disruptions in key energy transport routes have intensified, leading to a sharp rise in international oil prices.
Geopolitical tensions overshadowing production cuts: OPEC+ maintains quotas unchanged, paper adjustments fail to resolve physical supply dilemmas
OPEC+ major oil producers, led by Saudi Arabia and Russia, held a monthly video conference last Sunday and decided to keep the crude oil production quota for October unchanged, continuing the previous tone of stable production following a series of symbolic production increases.
Crypto prices
More
